Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

elotuzumab

(EH-loh-TOO-zoo-mab)
A drug used with dexamethasone and either lenalidomide or pomalidomide to treat adults with multiple myeloma. It is used in patients whose cancer was already treated with other anticancer therapies. Elotuzumab binds to a protein called CS1, which is found on myeloma cells and some types of immune cells. Elotuzumab may block CS1 and help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called Empliciti and HuLuc63.
More Information
Search NCI's Dictionary of Cancer Terms